Valproate Sodium Injection
Product Images NDC 0143-9637

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valproate Sodium (NDC 0143-9637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Valproate Sodium Injection Novaplus 1)

Chemical structure of Valproate Sodium showing a branched carbon chain with associated sodium ion (Na+). The structure includes a carboxylate group (COO-) linked to the branched alkyl chain, consistent with valproate sodium's molecular composition.*

FDA Label Image

Figure 1 (Valproate Sodium Injection Novaplus 2)

A line graph comparing the percentage reduction in CPS (complex partial seizures) rate between patients treated with Divalproex Sodium and a placebo. The x-axis shows the percentage of patients from 0 to 100%, and the y-axis shows the percentage reduction in CPS rate from -100% to +100%, with labels indicating improvement, no change, and worsening. The graph shows two lines: a solid line representing Divalproex Sodium and a dotted line representing placebo.*

FDA Label Image

Figure 2 (Valproate Sodium Injection Novaplus 3)

A graph showing the percentage reduction in CPS rate among patients treated with Valproate Sodium injection at high and low doses. The y-axis represents the percentage reduction in CPS rate, ranging from -100% (worsening) to 100% (improvement), with a zero line for no change. The x-axis represents the percentage of patients, ranging from 0 to 100%. The graph includes two curves: a solid line for high dose and a dotted line for low dose, comparing the distribution of response rates between the two dosing groups.*

FDA Label Image

Container Label (Valproate Sodium Injection Novaplus 4)

Label for Valproate Sodium Injection, USP 500 mg per 5 mL (100 mg/mL) intravenous injection by Hikma Pharmaceuticals USA Inc. It is a 5 mL single dose vial indicated for IV infusion only. The product is preservative free, with NDC 0143-9637-01 and includes storage instructions and manufacturing details.*

FDA Label Image

Plb783-nov.2 (Valproate Sodium Injection Novaplus 5)

Label for Valproate Sodium Injection, USP, 100 mg/mL by Hikma Pharmaceuticals USA Inc. The label specifies the product is for intravenous infusion only, provided in 10 single-dose vials of 5 mL each, containing 500 mg per 5 mL. It is preservative free, with storage instructions and manufacturer information included.*

FDA Label Image

Valproate Sodium Injection Novaplus 6

Label of Valproate Sodium injection 100 mg/mL by Hikma Pharmaceuticals USA Inc., showing a QR code with adjacent text fields for GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The text fields contain placeholder alphanumeric codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.